Sandu Pharmaceuticals Limited has announced the dispatch of its Annual Report for the Financial Year 2026-27. This report will be sent electronically to shareholders whose email addresses are registered with their Depository Participants (DP) or the Company/Registrar & Transfer Agent (RTA). For shareholders who have not registered their emails, a physical letter containing the web-link to the Annual Report has been sent.
Annual Report Distribution Underway
Sandu Pharmaceuticals Limited is proceeding with the distribution of its Annual Report for the financial year 2026-27. In line with current regulatory guidelines and a focus on environmental sustainability, the report is being disseminated primarily through electronic means. This approach ensures that shareholders receive timely access to the company’s performance and strategic overview for the concluded fiscal year.
Shareholder Communication Channels
Shareholders with registered email addresses with their Depository Participants (DP) or the Company’s Registrar & Transfer Agent (RTA) will receive the Annual Report via email. For those who have not provided or updated their email details, Sandu Pharmaceuticals is dispatching a physical letter. This letter includes the specific web-link and the exact path to access the complete Annual Report for FY 2026-27 on the company’s website.
AGM Details
The company also reminded shareholders that its 41st Annual General Meeting (AGM) is scheduled for Friday, September 11, 2026, at 4:30 PM IST. The meeting will be conducted virtually through Video Conferencing or Other Audio Visual Means (VC/OAVM).
Source: BSE
